Replimune (REPL) Cash from Operations (2017 - 2026)
Replimune (REPL) reported Cash from Operations of 56161000.0 for Q1 2026, down 4.52% on a YoY basis from 58821206.04 in Q1 2025, and up 14.85% sequentially from 65955000.0 in Q4 2025.
Replimune (REPL) Cash from Operations (2017 - 2026) Analysis & Trends
Replimune (REPL) has 10 years of Cash from Operations data on file, last reported at 56161000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations fell 4.52% year-over-year to 56161000.0; the trailing twelve-month figure through Mar 2026 stood at 280344000.0 (down 45.82% YoY), and the FY2026 full-year result was 280344000.0, down 45.82% from the prior year.
- Cash from Operations climbed to 56161000.0 in Q1 2026, from 65955000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 22557000.0 in Q1 2022 to a low of 81212000.0 in Q3 2025.
- A 5-year average of 47568705.88 and a median of 47123000.0 in 2023 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations advanced 11.36% in 2024 and tumbled 110.18% in 2025, its largest moves.
- Tracing REPL's Cash from Operations over 5 years: stood at 28589000.0 in 2022, then sank by 64.83% to 47123000.0 in 2023, then decreased by 7.62% to 50713000.0 in 2024, then tumbled by 30.06% to 65955000.0 in 2025, then grew by 14.85% to 56161000.0 in 2026.
- Business Quant data shows REPL's Cash from Operations at 56161000.0 in Q1 2026, 65955000.0 in Q4 2025, and 81212000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Replimune | 970.73 Mn | 970.73 Mn | - | -56.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -56.16 Mn |
| Mar 31, 2026 | -56.16 Mn |
| Dec 31, 2025 | -65.96 Mn |
| Dec 31, 2025 | -65.96 Mn |
| Sep 30, 2025 | -81.21 Mn |
| Sep 30, 2025 | -81.21 Mn |
| Jun 30, 2025 | -77.02 Mn |
| Jun 30, 2025 | -77.02 Mn |
| Mar 31, 2025 | -53.73 Mn |
| Mar 31, 2025 | -53.73 Mn |
| Dec 31, 2024 | -50.71 Mn |
| Dec 31, 2024 | -50.71 Mn |
| Sep 30, 2024 | -38.64 Mn |
| Sep 30, 2024 | -38.64 Mn |
| Jun 30, 2024 | -49.17 Mn |
| Jun 30, 2024 | -49.17 Mn |
| Mar 31, 2024 | -46.17 Mn |
| Mar 31, 2024 | -46.17 Mn |
| Dec 31, 2023 | -47.12 Mn |
| Dec 31, 2023 | -47.12 Mn |